ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,264 | -22.0% | 20,870 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $161,951 | +36.1% | 20,870 | 0.0% | 0.01% | +33.3% |
| Q1 2023 | $118,959 | -3.2% | 20,870 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $122,924 | +83.5% | 20,870 | 0.0% | 0.01% | +75.0% |
| Q3 2022 | $67,000 | -28.0% | 20,870 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $93,000 | -16.2% | 20,870 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $111,000 | -63.8% | 20,870 | 0.0% | 0.01% | -58.3% |
| Q4 2021 | $307,000 | – | 20,870 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |